.pf{position:relative;background-color:#fff;overflow:hidden;margin:0;border:0}.pc{position:absolute;border:0;padding:0;margin:0;top:0;left:0;width:100%;height:100%;overflow:hidden;display:block;transform-origin:0 0;-ms-transform-origin:0 0;-webkit-transform-origin:0 0}.bi{position:absolute;border:0;margin:0}.c{position:absolute;border:0;padding:0;margin:0;overflow:hidden;display:block}.t{position:absolute;white-space:pre;font-size:1px;transform-origin:0 100%;-ms-transform-origin:0 100%;-webkit-transform-origin:0 100%;unicode-bidi:bidi-override;-moz-font-feature-settings:"liga" 0}.t:after{content:''}.t:before{content:'';display:inline-block}.t span{position:relative;unicode-bidi:bidi-override}._{display:inline-block;color:transparent;z-index:-1}.pi{display:none}@media screen{.pf{margin:13px auto;box-shadow:1px 1px 3px 1px #333;border-collapse:separate}}.ff1{font-family:ff1;line-height:.895996;font-style:normal;font-weight:400;visibility:visible}.m0{transform:matrix(.320260,0,0,.320260,0,0);-ms-transform:matrix(.320260,0,0,.320260,0,0);-webkit-transform:matrix(.320260,0,0,.320260,0,0)}.ls1{letter-spacing:-.144135px}.ls0{letter-spacing:0}.ls2{letter-spacing:.100094px}.sc0{text-shadow:-.015em 0 transparent,0 .015em transparent,.015em 0 transparent,0 -.015em transparent}@media screen and (-webkit-min-device-pixel-ratio:0){.sc0{-webkit-text-stroke:.015em transparent;text-shadow:none}}.ws0{word-spacing:-9.845408px}.ws1{word-spacing:0}._0{margin-left:-1.042665px}.fc1{color:transparent}.fc0{color:#000}.fs0{font-size:44.201520px}.y1d{bottom:-387.840259px}.y1c{bottom:-351.685922px}.y1b{bottom:-325.989455px}.y1a{bottom:-300.139632px}.y19{bottom:-263.941698px}.y18{bottom:-238.091362px}.y17{bottom:-212.241538px}.y16{bottom:-186.545072px}.y15{bottom:-150.385734px}.y14{bottom:-124.535397px}.y13{bottom:-98.685061px}.y12{bottom:-72.989107px}.y11{bottom:-47.138771px}.y10{bottom:-10.953916px}.y0{bottom:0}.yf{bottom:14.89642px}.ye{bottom:50.901504px}.yd{bottom:76.751841px}.yc{bottom:112.911179px}.yb{bottom:138.607132px}.ya{bottom:164.457469px}.y9{bottom:200.655402px}.y8{bottom:226.505226px}.y7{bottom:252.201693px}.y6{bottom:278.052029px}.y5{bottom:303.902365px}.y4{bottom:329.752702px}.y3{bottom:365.758298px}.y2{bottom:401.943153px}.y1{bottom:507.293741px}.h3{height:31.726677px}.h1{height:507.29246px}.h2{height:507.295022px}.h0{height:1014.588763px}.w1{width:783.997438px}.w0{width:784px}.x0{left:0}.x1{left:91.984486px}

MEDT 315 Study Guide - Quiz Guide: Diabetic Nephropathy, Renal Vein, Multiple Myeloma

United States

Hematology I

Medical Technology

Prof

Marist College

Themes in Modern History

Anatomy & Physiology 

Microbiology

Immunology

Public Presentation

American Literature II

Clinical Microbiology I

Clinical Chemistry I

Clinical Immunology/Immunohematology I

Philosophical Perspectives

Psychology Seminar

General Biology I

General Chemistry I: Introduction to Inorganic Chemistry

MEDT 315 Lecture Notes - Lecture 24: Diabetic Nephropathy, Microalbuminuria, Myoglobin

MEDT 315 Study Guide - Quiz Guide: Diabetic Nephropathy, Renal Vein, Multiple Myeloma

Get access

Related Documents

MEDT 315 Lecture Notes - Lecture 24: Diabetic Nephropathy, Microalbuminuria, Myoglobin

MEDT 315 Lecture Notes - Lecture 14: Refractometer, Immunoassay, Creatinine

KIN 2500 Chapter : Chapters 18 Urinary